Adult ECAT protocol

Substance withdrawal (suspected)

A8.2 Published: December 2023. Printed on 1 Jul 2024.

QR code link to ECI website

Get the latest version


Any person, 16 years and over, presenting with actual or potential alcohol or drug withdrawal.

This protocol is intended to be used by registered and enrolled nurses within their scope of practice and as outlined in The Use of Emergency Care Assessment and Treatment Protocols (PD2024_011). Sections marked triangle or diamond indicate the need for additional prerequisite education prior to use. Check the medication table for dose adjustments and links to relevant reference texts.

History prompts, signs and symptoms

These are not exhaustive lists. Maintain an open mind and be aware of cognitive bias.

History prompts

  • Presenting complaint
  • Onset of symptoms
  • Time of last alcohol or drug use
  • Full alcohol and/or drug consumption history – consider risks of polydrug use
  • History of previous substance withdrawal
  • Pain assessment – PQRST
  • Pre-hospital treatment
  • Past admissions
  • Medical and surgical history
  • History of liver disease and/or Wernicke encephalopathy
  • Current medications
  • Known allergies

Signs and symptoms

  • Tachycardia
  • Agitation or irritability
  • Insomnia
  • Palpitations
  • Headache
  • Diaphoresis
  • Tremors
  • Hallucination
  • Delirium
  • Vomiting and/or diarrhoea
  • Muscle cramps

Red flags

Recognise: identify indicators of actual or potential clinical severity and risk of deterioration.

Respond: carefully consider alternative ECAT protocol. Escalate as per clinical reasoning and local CERS protocol, and continue treatment.

Historical

  • Frequent presentations to emergency with or without management plan
  • History of severe withdrawal or seizure
  • Recent history of heavy drug and/or alcohol   use
  • Polysubstance use
  • Over 65 years or over 55 years in Aboriginal or Torres Strait Islander patients
  • Pregnancy

Clinical

Remember adult at risk: patient or carer concern, frailty, multiple comorbidities or unplanned return.

Clinical assessment and specified intervention (A to G)

If the patient has any Yellow or Red Zone observations or additional criteria (as per the relevant NSW Standard Emergency Observation Chart), refer and escalate as per local CERS protocol and continue treatment.

Position

AssessmentIntervention

General appearance/first impressions

Position of comfort

Minimise stress by providing a quiet, calm, safe and private space

Keep intoxicated patients under close observation until their intoxication diminishes and they are considered safe

De-escalation techniques may be required for patients experiencing agitation or distress

Airway

AssessmentIntervention

Patency of airway

Maintain airway patency

Consider airway opening manoeuvres and positioning

Breathing

AssessmentIntervention

Respiratory rate and effort

Auscultate chest (breath sounds)

Oxygen saturation (SpO2)

Assist ventilation, as clinically indicated

Consider oxygen if dyspnoeic, titrate oxygen to maintain SpO2 over 93%

Patients at risk of hypercapnia, maintain SpO2 at 88–92%

Monitor closely for aspiration pneumonia and/or respiratory depression

Circulation

AssessmentIntervention

Perfusion (capillary refill, skin warmth and colour)

Pulse

Blood pressure

Cardiac rhythm

Assess circulation

Attach cardiac monitor and complete 12 lead ECG if BP/HR are within the Yellow or Red Zones, or where clinically relevant e.g. irregular pulse, palpitations, syncope, shock, respiratory compromise, cardiac history or clinical concern

IVC and/or pathology

Insert IV cannula, if trained and clinically indicated

If unable to obtain IV access, consider intraosseous, if trained

See pathology section

Signs of shock:

tachycardia and CRT 3 seconds and over

and/or abnormal skin perfusion

and/or hypotension

If signs of shock present and/or SBP less than 90 mmHg, give 250 mL of sodium chloride 0.9% IV/intraosseous bolus

Repeat every 10 minutes (up to 1000 mL) until SBP over 90 mmHg or signs of shock have resolved

Disability

AssessmentIntervention

GCS, pupillary response and limb strength

Obtain baseline and repeat assessment as clinically indicated

Pain

Assess pain. If indicated, give early analgesia as per specific treatment section then resume A to G assessment

Exposure

AssessmentIntervention
Temperature – pyrexia is common in acute withdrawal

Measure temperature

Maintain normothermia

Skin inspection, including posterior surfaces

Check and document any abnormalities

Fluids

AssessmentIntervention
Hydration status: last ate, drank, bowels opened, passed urine or vomited

Commence fluid balance chart, as required

Encourage oral hydration

Nausea and/or vomiting If present, see nausea and/or vomiting section

Glucose

Assessment Intervention
BGL

Measure BGL

If patient is experiencing alcohol withdrawal or is at high risk of thiamine deficiency and is hypoglycaemic: give thiamine before glucose, or as soon as possible after. See thiamine section

If BGL less than 4 mmol/L with NO decrease in level of consciousness (Yellow Zone criteria):

  • give quick-acting carbohydrate: sugary soft drink, fruit juice or 40% glucose gel, up to 15 g, buccal
  • reassess BGL in 15–30 minutes and repeat treatment until BGL over 4 mmol/L

If BGL less than 4 mmol/L WITH a decrease in level of consciousness (Red Zone criteria) OR the patient is unable to tolerate oral intake:

  • give 40% glucose gel, up to 15 g, buccally in incremental doses, as tolerated, while establishing IV access
  • give 10% glucose 200 mL by IV infusion over 15 minutes, once only
  • if delay in IV access, give glucagon 1 mg IM, once only
  • reassess BGL in 15 minutes

If the patient is unconscious or peri-arrest:

  • give 50% glucose 50 mL by slow IV injection, once only. Use with caution as extravasation can cause necrosis
  • if delay in IV access, give glucagon 1 mg IM, once only
  • reassess BGL in 15 minutes

Once stabilised, give patient long-acting carbohydrate and continue to check BGL hourly, or as clinically indicated

Repeat and document assessment and observations to monitor responses to interventions, identify developing trends and clinical deterioration. Escalate care as required according to the local CERS protocol.

Focused assessment

Complete substance withdrawal focused assessment.

Consider mental health focused assessment.

Clinical tips are provided in Management of Withdrawal from Alcohol and Other Drugs Clinical Guidance to support clinicians to provide care that meets the needs of patients from specific population groups undergoing substance withdrawal.

Precautions and notes

  • Be familiar with any new or recent drug alerts available at Public drug warnings, NSW Health.
  • Determine if the patient is currently a client of other service providers, and the need for their input while patient is in the emergency department.
  • Delirium tremens (DTs) begins 48–72 hours after the last drink. DTs have serious medically associated risks, including changes to breathing, blood circulation, core body temperature and electrolytes.
  • Thiamine is an essential vitamin in the body’s metabolic processes. Malnutrition is high in people with alcohol and drug dependence. Failure to restore thiamine can lead to Wernicke-Korsakoff syndrome or Wernicke encephalopathy.

Interventions and diagnostics

Specific treatment

  • Continue to monitor and assess withdrawal symptoms, using appropriate opioid or alcohol withdrawal scale
  • Refer to local drug and alcohol service promptly, if available

For patients less than 65 years and not pregnant:

  • give diazepam 10 mg orally once only. Escalation is required for ongoing management
  • continue hourly withdrawal scale and monitoring

Analgesia

If pain score 1–6 (mild–moderate): give paracetamol 1000 mg orally once only.

If severe pain present, give analgesia and escalate as per local CERS protocol.


Nausea and/or vomiting

If nausea and/or vomiting is present, give:

  • metoclopramide 10 mg orally or IV/IM once only (over 20 years only)
  • or ondansetron 4 mg orally or IV/IM. If symptoms persist after 60 minutes, repeat once, maximum dose 8 mg
  • or prochlorperazine 5 mg orally once only or 12.5 mg IV/IM once only

Choice of antiemetic should be determined by cause of symptoms.


Thiamine

If patient is experiencing alcohol withdrawal, or is at high risk of thiamine deficiency (e.g. those who drink large amounts of alcohol or who are severely malnourished), then:

  • monitor using alcohol withdrawal scale
  • give thiamine 300 mg IV/IM once only

If hypoglycaemic: thiamine should be given before glucose, or as soon as possible. Glucose can further deplete thiamine stores and precipitate Wernicke encephalopathy.


Radiology

Not usually indicated. If there is concern for urgent radiology, escalate care as per local CERS protocol.


Pathology

  • FBC, UEC, LFT
  • Alcohol withdrawal: coags

Medications

The shaded sections in this protocol are only to be used by registered nurses who have completed the required education.

Drag the table right to view more columns or turn your phone to landscape

Drug Dose Route Frequency

10 mg

Oral

Once only

1 mg

IM

Once only

200 mL

IV infusion over 15 minutes

Once only

Glucose 40% gel
(0.4 g/mL)

15 g

Buccal

Repeat after 15 minutes if required

50 mL

Slow IV injection

Once only

Metoclopramide R

Over 20 years:
10 mg

Oral/IV/IM

Once only

Ondansetron

4 mg

Maximum dose 8 mg

Oral/IV/IM

Repeat once if required after 60 minutes

Oxygen

2–15 L/min, device dependent

Inhalation

Continuous

Paracetamol H

1000 mg

Oral

Pain score 1–10

Once only

5 mg

Oral

Once only

OR

12.5 mg

IV/IM

Once only

Sodium chloride 0.9%

250 mL

Maximum dose 1000 mL

IV/intraosseous

Bolus

Repeat every 10 minutes (up to 1000 mL) until SBP over 90 mmHg or signs of shock have resolved

300 mg

IV/IM

Once only

If hypoglycaemic: thiamine should be given before glucose, or as soon as possible. Glucose can further deplete thiamine stores and precipitate Wernicke encephalopathy

Medications with contraindications or requiring dose adjustment are marked:

  • H for patients with known hepatic impairment
  • R for patients with known renal impairment.

Escalate to medical or nurse practitioner.

References

Hide references

Evidence informed

Information was drawn from evidence-based guidelines and a review of latest available research. For more information, see the development process.

Collaboration

This protocol was developed by the ECAT Working Group, led by the Agency for Clinical Innovation. The group involved expert medical, nursing and allied health representatives from local health districts across NSW. Consensus was reached on all recommendations included within this protocol.

Currency Due for review: Jan 2026. Based on a regular review cycle.
Feedback Email ACI-ECIs@health.nsw.gov.au

Accessed from the Emergency Care Institute website at https://aci.health.nsw.gov.au/ecat/adult/substance-withdrawal

Back to top